WUXIHYBRID Trademark

Trademark Overview

On Monday, April 12, 2021, a trademark application was filed for WUXIHYBRID with the United States Patent and Trademark Office. The USPTO has given the WUXIHYBRID trademark a serial number of 90638849. The federal status of this trademark filing is REGISTERED as of Tuesday, April 25, 2023. This trademark is owned by WuXi Biologics Ireland Limited. The WUXIHYBRID trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals, biopharmaceuticals, nutraceuticals, vitamins by pharmaceutical compounders

Product development for others; Pharmaceutical drug development services; Scientific research and development; pharmaceutical research services; Research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Research in the field of biomedical science; Pharmaceutical preparations and medicines development; Research and development services in the field of antibodies
wuxihybrid

General Information

Serial Number90638849
Word MarkWUXIHYBRID
Filing DateMonday, April 12, 2021
Status700 - REGISTERED
Status DateTuesday, April 25, 2023
Registration Number7037834
Registration DateTuesday, April 25, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceuticals, biopharmaceuticals, nutraceuticals, vitamins by pharmaceutical compounders
Description of MarkThe mark consists of the word WuXiHybrid with an eyeball as the dot for the "i's" with a double healix shape that resembles a mouth with teeth connecting the eyes, and the "Y" in thinner text with double lines.
Goods and ServicesProduct development for others; Pharmaceutical drug development services; Scientific research and development; pharmaceutical research services; Research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Research in the field of biomedical science; Pharmaceutical preparations and medicines development; Research and development services in the field of antibodies

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, July 19, 2021
Primary Code040
First Use Anywhere DateWednesday, November 30, 2022
First Use In Commerce DateWednesday, November 30, 2022
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 19, 2021
Primary Code042
First Use Anywhere DateWednesday, November 30, 2022
First Use In Commerce DateWednesday, November 30, 2022

Trademark Owner History

Party NameWuXi Biologics Ireland Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91X56F
IE
Party NameWuXi Biologics Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91X56F
IE
Party NameWuXi Biologics Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91X56F
IE

Trademark Events

Event DateEvent Description
Tuesday, April 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 21, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 20, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 23, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, January 30, 2023USE AMENDMENT FILED
Wednesday, February 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 30, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 2, 2022ASSIGNED TO LIE
Friday, April 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 22, 2021NON-FINAL ACTION E-MAILED
Monday, November 22, 2021NON-FINAL ACTION WRITTEN
Saturday, November 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 20, 2021NON-FINAL ACTION E-MAILED
Saturday, November 20, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 17, 2021ASSIGNED TO EXAMINER
Monday, August 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 2, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, August 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 20, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 4, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, May 4, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 15, 2021NEW APPLICATION ENTERED

Related Keywords

wuxihybrid development research pharmaceutical services field biochemical technology analysis consulting biomedical